wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q54965602-A52E5E81-9314-44A6-BC5E-939BBCBFC34F
Q54965602-A52E5E81-9314-44A6-BC5E-939BBCBFC34F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54965602-A52E5E81-9314-44A6-BC5E-939BBCBFC34F
How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies.
P2860
Q54965602-A52E5E81-9314-44A6-BC5E-939BBCBFC34F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54965602-A52E5E81-9314-44A6-BC5E-939BBCBFC34F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eba72ca0e8653514fd4e590824e8c9234fec3206
P2860
Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-